These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 11356238)

  • 41. Long-term effectiveness and cost of a systematic care program for bipolar disorder.
    Simon GE; Ludman EJ; Bauer MS; Unützer J; Operskalski B
    Arch Gen Psychiatry; 2006 May; 63(5):500-8. PubMed ID: 16651507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.
    Miklowitz DJ; Otto MW; Frank E; Reilly-Harrington NA; Wisniewski SR; Kogan JN; Nierenberg AA; Calabrese JR; Marangell LB; Gyulai L; Araga M; Gonzalez JM; Shirley ER; Thase ME; Sachs GS
    Arch Gen Psychiatry; 2007 Apr; 64(4):419-26. PubMed ID: 17404119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma: study protocol for a randomized controlled trial.
    Moreno-Alcázar A; Radua J; Landín-Romero R; Blanco L; Madre M; Reinares M; Comes M; Jiménez E; Crespo JM; Vieta E; Pérez V; Novo P; Doñate M; Cortizo R; Valiente-Gómez A; Lupo W; McKenna PJ; Pomarol-Clotet E; Amann BL
    Trials; 2017 Apr; 18(1):160. PubMed ID: 28376919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults.
    van Dessel N; den Boeft M; van der Wouden JC; Kleinstäuber M; Leone SS; Terluin B; Numans ME; van der Horst HE; van Marwijk H
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD011142. PubMed ID: 25362239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis.
    Goldberg JF; Harrow M
    J Affect Disord; 2005 Dec; 89(1-3):79-89. PubMed ID: 16249035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid.
    Namjoshi MA; Risser R; Shi L; Tohen M; Breier A
    J Affect Disord; 2004 Sep; 81(3):223-9. PubMed ID: 15337326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders - an 18-month prospective study.
    Arvilommi P; Suominen K; Mantere O; Leppämäki S; Valtonen H; Isometsä E
    J Affect Disord; 2014 Feb; 155():110-7. PubMed ID: 24262639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of comorbid major depressive disorder or bipolar disorder on cognitive behavioral therapy for social anxiety disorder.
    Fracalanza K; McCabe RE; Taylor VH; Antony MM
    J Affect Disord; 2014 Jun; 162():61-6. PubMed ID: 24767007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving functional outcome in bipolar disorder: A pilot study on metacognitive training.
    Haffner P; Quinlivan E; Fiebig J; Sondergeld LM; Strasser ES; Adli M; Moritz S; Stamm TJ
    Clin Psychol Psychother; 2018 Jan; 25(1):50-58. PubMed ID: 28857347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year.
    Lam DH; Watkins ER; Hayward P; Bright J; Wright K; Kerr N; Parr-Davis G; Sham P
    Arch Gen Psychiatry; 2003 Feb; 60(2):145-52. PubMed ID: 12578431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune response to stress induction as a predictor of cognitive-behavioral therapy outcomes in adolescent mood disorders: A pilot study.
    Pearlstein JG; Staudenmaier PJ; West AE; Geraghty S; Cosgrove VE
    J Psychiatr Res; 2020 Jan; 120():56-63. PubMed ID: 31634750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancing quality of life among adolescents with bipolar disorder: A randomized trial of two psychosocial interventions.
    O'Donnell LA; Axelson DA; Kowatch RA; Schneck CD; Sugar CA; Miklowitz DJ
    J Affect Disord; 2017 Sep; 219():201-208. PubMed ID: 28570966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing the effectiveness of imagery focussed cognitive therapy to group psychoeducation for patients with bipolar disorder: A randomised trial.
    van den Berg KC; Hendrickson AT; Hales SA; Voncken M; Keijsers GPJ
    J Affect Disord; 2023 Jan; 320():691-700. PubMed ID: 36206888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder.
    Carney CE; Segal ZV; Edinger JD; Krystal AD
    J Clin Psychiatry; 2007 Feb; 68(2):254-60. PubMed ID: 17335324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mindfulness-based cognitive therapy for nonremitted patients with bipolar disorder.
    Deckersbach T; Hölzel BK; Eisner LR; Stange JP; Peckham AD; Dougherty DD; Rauch SL; Lazar S; Nierenberg AA
    CNS Neurosci Ther; 2012 Feb; 18(2):133-41. PubMed ID: 22070469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial.
    Ott CV; Vinberg M; Bowie CR; Christensen EM; Knudsen GM; Kessing LV; Miskowiak KW
    Trials; 2018 Sep; 19(1):487. PubMed ID: 30208971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: development and preliminary results.
    Pavuluri MN; Graczyk PA; Henry DB; Carbray JA; Heidenreich J; Miklowitz DJ
    J Am Acad Child Adolesc Psychiatry; 2004 May; 43(5):528-37. PubMed ID: 15100559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
    Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
    Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study.
    Deckersbach T; Nierenberg AA; McInnis MG; Salcedo S; Bernstein EE; Kemp DE; Shelton RC; McElroy SL; Sylvia LG; Kocsis JH; Bobo WV; Friedman ES; Singh V; Tohen M; Bowden CL; Ketter TA; Calabrese JR; Thase ME; Reilly-Harrington NA; Rabideau DJ; Kinrys G; Kamali M
    J Clin Psychiatry; 2016 Jan; 77(1):100-8. PubMed ID: 26845265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.